I see them as competing with PGL in this space of primary liver cancer, so if they can't make it to the next level I guess it is good news for PGL.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025